162 related articles for article (PubMed ID: 32631090)
1. Novel regulators of PrP
Colini Baldeschi A; Vanni S; Zattoni M; Legname G
Expert Opin Ther Targets; 2020 Aug; 24(8):759-776. PubMed ID: 32631090
[TBL] [Abstract][Full Text] [Related]
2. Tackling prion diseases: a review of the patent landscape.
Zattoni M; Legname G
Expert Opin Ther Pat; 2021 Dec; 31(12):1097-1115. PubMed ID: 34134584
[No Abstract] [Full Text] [Related]
3. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
4. Prion protein self-interactions: a gateway to novel therapeutic strategies?
Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
[TBL] [Abstract][Full Text] [Related]
5. Therapy in prion diseases: from molecular and cellular biology to therapeutic targets.
Krammer C; Vorberg I; Schätzl HM; Gilch S
Infect Disord Drug Targets; 2009 Feb; 9(1):3-14. PubMed ID: 19200010
[TBL] [Abstract][Full Text] [Related]
6. Gene and cell therapy for prion diseases.
Relaño-Ginés A; Gabelle A; Lehmann S; Milhavet O; Crozet C
Infect Disord Drug Targets; 2009 Feb; 9(1):58-68. PubMed ID: 19200016
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the PrPc Amino-Terminal Domain in Prion Species Barriers.
Davenport KA; Henderson DM; Mathiason CK; Hoover EA
J Virol; 2016 Dec; 90(23):10752-10761. PubMed ID: 27654299
[TBL] [Abstract][Full Text] [Related]
8. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
Singh J; Udgaonkar JB
Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
[TBL] [Abstract][Full Text] [Related]
9. Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease.
White MD; Farmer M; Mirabile I; Brandner S; Collinge J; Mallucci GR
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10238-43. PubMed ID: 18632556
[TBL] [Abstract][Full Text] [Related]
10. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
[TBL] [Abstract][Full Text] [Related]
11. Metabolic aspects of prion diseases: an overview.
Vranac T; Bresjanac M
Curr Drug Targets; 2010 Oct; 11(10):1207-17. PubMed ID: 20840065
[TBL] [Abstract][Full Text] [Related]
12. Alkylating antitumor drug mechlorethamine conceals a structured PrP domain and inhibits in vitro prion amplification.
Zhou X; Bi H; Wong J; Shimoji M; Wang Y; Yuan J; Xiao X; Wang GX; Zou WQ
J Toxicol Environ Health A; 2011; 74(22-24):1493-503. PubMed ID: 22043910
[TBL] [Abstract][Full Text] [Related]
13. Prion diseases and emerging prion diseases.
Yokoyama T; Mohri S
Curr Med Chem; 2008; 15(9):912-6. PubMed ID: 18473798
[TBL] [Abstract][Full Text] [Related]
14. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
15. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
[TBL] [Abstract][Full Text] [Related]
16. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
[TBL] [Abstract][Full Text] [Related]
17. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
18. RNAi: a novel strategy for the treatment of prion diseases.
Kong Q
J Clin Invest; 2006 Dec; 116(12):3101-3. PubMed ID: 17143323
[TBL] [Abstract][Full Text] [Related]
19. [Systematic review of the therapeutics for prion diseases].
Sakaguchi S
Brain Nerve; 2009 Aug; 61(8):929-38. PubMed ID: 19697882
[TBL] [Abstract][Full Text] [Related]
20. Nonneuronal cellular prion protein.
Fournier JG
Int Rev Cytol; 2001; 208():121-60. PubMed ID: 11510567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
